EUVIMEDEUVIMED entdecken
Crossref

Management of Immune Thrombocytopenic Patient Associated with COVID-19 Viral Infection: A Case Series

Deniz İNCAMAN

Turkish Journal of Internal Medicine · 2022

DOI: 10.46310/tjim.1009709 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Internal Medicine, 2022. Verfasst von Deniz İNCAMAN. Die Arbeit nennt 13 Literaturangaben. Gefördert von: yok.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe thrombocytopenia is a cause of morbidity and mortality for patients with COVID-19 infection. The common causes of thrombocytopenia in these patients are; sepsis, drug-associated, disseminated intravascular coagulation (DIC), heparin-associated thrombocytopenia (HIT), microangiopathic hemolytic anemia (MAHA). Recently, cases of COVID-19 infection-associated Immune thrombocytopenic purpura (ITP) have been reported in the literature. In our study, we will present our case series consisting of 10 patients associated with COVID-19

Förderung

  • yok

Zitieren

APA

İNCAMAN, D. (2022). Management of Immune Thrombocytopenic Patient Associated with COVID-19 Viral Infection: A Case Series. Turkish Journal of Internal Medicine. https://doi.org/10.46310/tjim.1009709

Vancouver

İNCAMAN D. Management of Immune Thrombocytopenic Patient Associated with COVID-19 Viral Infection: A Case Series. Turkish Journal of Internal Medicine. 2022. doi:10.46310/tjim.1009709

BibTeX
@article{NCAMAN2022,
  author = {İNCAMAN, Deniz},
  title = {Management of Immune Thrombocytopenic Patient Associated with COVID-19 Viral Infection: A Case Series},
  journal = {Turkish Journal of Internal Medicine},
  year = {2022},
  doi = {10.46310/tjim.1009709}
}
Kostenlos starten →